Turn Therapeutics Inc.
NASDAQ: TTRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bradley E. Burnam
- Employees
- 2
- Headquarters
- Westlake Village, United States
- IPO year
- 2025
- Market cap
- $181.4M
- Website
- https://www.turntherapeutics.com
Loading TTRX…
Loading profile data…Frequently asked questions about TTRX
What does Turn Therapeutics Inc. (TTRX) do?
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated i...
Where does TTRX trade?
Turn Therapeutics Inc. (TTRX) trades on the NASDAQ Global Select.
What sector is TTRX in?
Turn Therapeutics Inc. (TTRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Turn Therapeutics Inc.?
Bradley E. Burnam is the chief executive officer of Turn Therapeutics Inc. (TTRX).
Where is Turn Therapeutics Inc. headquartered?
Turn Therapeutics Inc. is headquartered in United States.
Does TTRX pay a dividend?
Turn Therapeutics Inc. (TTRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TTRX go public?
Turn Therapeutics Inc. (TTRX) completed its initial public offering in 2025.